Table 4 Exploratory analysis of chemotherapy classes as risk factors for CDI.

From: Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients

Risk factor for CDI-Chemotherapy classes

Odds ratio

95% CI

p-value

Platinum drugs

OR = 0.55

0.27–1.10

p = 0.091

Topoisomerase inhibitors

OR = 0.59

0.30–1.17

p = 0.133

Anthracyclines

OR = 0.52

0.27–1.02

p = 0.056

Taxanes

OR = 0.42

0.15–1.18

p = 0.100